对于M描述符的不同方法,用于SCLC中未来的寡头转移性疾病的分期:一个横截面的生存分析
Melahat Uzel Şener1, Pınar Akın Kabalak2, Suna Kavurgacı2
1Department of Chest Diseases, University of Health Sciences, Ankara Atatürk Sanatorium Training and Research Hospital, Keçiören, Ankara, Turkey. melahatuzeldr@yahoo.com.tr.
概括
在广泛的小细胞肺癌 (ES-SCLC) 中,转移的数量比转移器官的数量更好地预测生存. 在M1c1和M1c2组之间,生存结果没有显著差异.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 癌症研究 癌症研究
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有有限治疗选择的侵袭性恶性瘤.
- 扩散阶段SCLC (ES-SCLC) 的特点是扩散的转移.
- 准确的预后因素对于引导ES-SCLC治疗决策至关重要.
研究的目的:
- 评估ES-SCLC中寡头转移的预后意义.
- 评估M描述因子 (转移) 对生存结果的影响.
- 为了比较不同类别的转移性负担之间的生存率.
主要方法:
- 一个多中心的回顾性研究,对439名新诊断ES-SCLC的患者 (2010-2020).
- 根据转移的数量和位置 (第9个阶段-M描述符) 将患者分为四组.
- 分析了三年无进展生存率 (PFS) 和整体生存率 (OS).
主要成果:
- 在第一组 (单个转移,单个器官) 和第二组 (2-5转移,单个器官) 中,无进展生存 (PFS) 是最高的.
- 总体存活率 (OS) 在第一组明显高于其他组.
- 在M1c1和M1c2亚组之间没有观察到显著的生存差异,但M1b显示出比M1c1/M1c2.2.更好的生存率.
结论:
- 转移的数量,而不是转移器官的数量,似乎是ES-SCLC中更重要的预后因素.
- 在M1c1和M1c2分类之间,生存结果没有显著差异.
- 进一步的研究可能会完善ES-SCLC的分期和预后模型.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
相关概念视频
Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
